Skip to main content
Research

Publications: Prof Maralyn Druce

Papaioannou C, Druce M ( 2022 ) . Preoperative medical treatments and surgical approaches for acromegaly: A systematic review . Clinical Endocrinology vol. 98 , ( 1 ) 14 - 31 .
van Haalen FM, Kaya M, Pelsma ICM, Dekkers OM, Biermasz NR, Cannegieter SC, Huisman MV, van Vlijmen BJM et al. ( 2022 ) . Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN) . Orphanet Journal of Rare Diseases vol. 17 , ( 1 )
Mourougavelou V, Wu X, Goodchild E, Argentesi G, Laycock K, Akker S, Druce M, Sze C et al. ( 2021 ) . Method of venesection and location of peripheral sample alter adrenal venous sampling results and interpretation in primary aldosteronism . Endocrine Abstracts
O’Toole SM, Hornby C, Sze WC, Hannon MJ, Akker SA, Druce MR, Waterhouse M, Dawnay A et al. ( 2021 ) . Performance evaluation of scoring systems for predicting post‐operative hypertension cure in primary aldosteronism . Clinical Endocrinology vol. 95 , ( 4 ) 576 - 586 .
Divanovic A, Druce MR ( 2021 ) . Effect of Conventional Chemotherapy in Patients With Neuroendocrine Tumours: A Systematic Review . Journal of the Endocrine Society vol. 5 , ( Supplement_1 ) a1015 - a1016 .
Bryce J, Di Guisto V, Ali SR, Alexandraki K, Badiu C, Baronio F, Biermasz NR, Brandi ML et al. ( 2021 ) . The Use Of e-REC For Capturing The Occurrence Of COVID-19 Infections In People With Rare Endocrine Conditions . HORMONE RESEARCH IN PAEDIATRICS . vol. 94 , 48 - 49 .
Goncharova M, Grey J, Druce M ( 2020 ) . Impact of gastrointestinal symptoms on quality of life in MEN2 . Clinical Endocrinology
Hussein Z, Glynn N, Martin N, Alkrekshi A, Mendoza N, Nair R, McCullough K, Marcus HJ et al. ( 2020 ) . Temporal trends in craniopharyngioma management and long‐term endocrine outcomes: A multicentre cross‐sectional study . Clinical Endocrinology vol. 94 , ( 2 ) 242 - 249 .
Moss L, Cox C, Wadsley J, Newbold K, Strachan MWJ, Druce M, Tolley N, Graham K et al. ( 2020 ) . Medullary Thyroid Cancer Patient’s Assessment of Quality of Life Tools: Results from the QaLM Study . European Thyroid Journal vol. 10 , ( 1 ) 72 - 78 .
Marques P, Magalhães D, Caimari F, Hernández RL, Collier D, Lim C, Stals K, Ellard S et al. ( 2020 ) . Phenotypic differences between patients with familial pituitary neuroendocrine tumours due to MEN1 or AIP mutations . Endocrine Abstracts
O’Toole SM, Sze W-CC, Chung T-T, Akker SA, Druce MR, Waterhouse M, Pitkin S, Dawnay A et al. ( 2020 ) . Low-grade Cortisol Cosecretion Has Limited Impact on ACTH-stimulated AVS Parameters in Primary Aldosteronism . The Journal of Clinical Endocrinology & Metabolism vol. 105 , ( 10 ) e3776 - e3784 .
White BE, Druce MR, Grozinsky-Glasberg S, Srirajaskanthan R, Gamper EM, Gray D, Mujica-Mota R, Ramage JK ( 2020 ) . Health-related quality of life in neuroendocrine neoplasms: a critical review . Endocrine Related Cancer vol. -1 , ( aop ) r267 - r280 .
Marques P, Caimari F, Hernández-Ramírez LC, Collier D, Iacovazzo D, Ronaldson A, Magid K, Lim CT et al. ( 2020 ) . Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors . The Journal of Clinical Endocrinology & Metabolism vol. 105 , ( 6 ) e2247 - e2260 .
Sundaralingam A, Cuttle R, Druce M, Nowosinska E, Giaslakiotis K, Sheaff M, Ricketts W ( 2020 ) . 43 A comparison of radiological and pathological staging in pulmonary carcinoid tumours . Lung Cancer vol. 139 ,
Gul F, Stiles C, Dorward N, Grieve J, Druce M, Akker S, Waterhouse M, Evanson J et al. ( 2019 ) . Does volumetric MRI (3D-SGE sequence) imaging enhance diagnostic rates in Cushing's disease? . Endocrine Abstracts
Chowdhury TA, Khan H, Druce MR, Drake WM, Rajakariar R, Thuraisingham R, Dobbie H, Parvanta L et al. ( 2019 ) . Flipped learning: Turning medical education upside down . Future Healthcare Journal vol. 6 , ( 3 ) 192 - 195 .
Lim ES, Shah SG, Waterhouse M, Akker S, Drake W, Plowman N, Berney DM, Richards P et al. ( 2019 ) . Impact of thyroiditis on 131I uptake during ablative therapy for differentiated thyroid cancer . Endocrine Connections vol. -1 , ( aop ) 571 - 578 .
Lim ES, Shah SG, Waterhouse M, Akker S, Drake W, Plowman N, Berney DM, Richards P et al. ( 2019 ) . Impact of thyroiditis on 131I uptake during ablative therapy for differentiated thyroid cancer . Endocrine Connections vol. 8 , ( 5 ) 454 - 461 .
Hu MI, Elisei R, Dedecjus M, Popovtzer A, Druce M, Kapiteijn E, Pacini F, Locati L et al. ( 2019 ) . Safety and efficacy of two starting doses of vandetanib in advanced medullary thyroid cancer . Endocrine Related Cancer vol. 26 , ( 2 ) 241 - 250 .
Castinetti F, Waguespack SG, Machens A, Uchino S, Hasse-Lazar K, Sanso G, Else T, Dvorakova S et al. ( 2019 ) . Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study . The Lancet Diabetes & Endocrinology vol. 7 , ( 3 ) 213 - 220 .
Ho W, Druce M ( 2018 ) . Quality of life in patients with adrenal disease: A systematic review . Clinical Endocrinology vol. 89 , ( 2 ) 119 - 128 .
Mitravela V-I, Glynn N, Waterhouse M, Akker S, Korbonits M, Drake W, Berney D, Plowman N et al. ( 2018 ) . Treatment strategies in medullary thyroid carcinoma - outcome following initial surgery with a curative, debulking or prophylactic intent . Endocrine Abstracts
Stiles CE, Daly S, Druce M ( 2018 ) . Insulinoma presenting with nocturnal seizures . Endocrine Abstracts
Ruiz-Babot G, Balyura M, Hadjidemetriou I, Ajodha SJ, Taylor DR, Ghataore L, Taylor NF, Schubert U et al. ( 2018 ) . Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells . Cell Reports vol. 22 , ( 5 ) 1236 - 1249 .
Iacovazzo D, Kumar A, Abbs S, Solomon A, Korbonits M, Druce M ( 2017 ) . A novel variant in the androgen receptor gene causing familial mild androgen insensitivity syndrome . Endocrine Abstracts
O’Shea T, Druce M ( 2017 ) . When should genetic testing be performed in patients with neuroendocrine tumours? . Reviews in Endocrine and Metabolic Disorders vol. 18 , ( 4 ) 499 - 515 .
Sze CWC, O'Toole SM, Tirador RK, Akker SA, Matson M, Perry L, Druce MR, Dekkers T et al. ( 2017 ) . Adrenal Vein Catecholamine Levels and Ratios: Reference Intervals Derived from Patients with Primary Aldosteronism . Hormone and Metabolic Research vol. 49 , ( 06 ) 418 - 423 .
Druce M, Howden S ( 2017 ) . New perspectives on health professions students’ e-learning: Looking through the lens of the “visitor and resident” model . Medical Teacher vol. 39 , ( 7 ) 704 - 709 .
Tufton N, Gunganah K, Hussain S, Druce M, Carpenter R, Ashby M, Drake WM, Akker SA ( 2017 ) . Alpha blockade—not to be underdone . vol. 86 , is. 2 , pp. 306 - 308 . Wiley
Chowdhury TA, Druce MR, Drake WM, Rajakariar R, Thuraisingham R, Dobbie H, Parvanta L, Chinegwundoh F et al. ( 2017 ) . An evaluation of "flipped learning" in undergraduate teaching in endocrinology and diabetes . DIABETIC MEDICINE . vol. 34 , 109 - 109 .
Hannon MJ, Sze WC, Carpenter R, Parvanta L, Matson M, Sahdev A, Druce MR, Berney DM et al. ( 2016 ) . Clinical outcomes following unilateral adrenalectomy in patients with primary aldosteronism . QJM vol. 110 , ( 5 ) 277 - 281 .
Tufton N, Shapiro L, Srirangalingam U, Richards P, Sahdev A, Kumar AV, McAndrew L, Martin L et al. ( 2016 ) . Outcomes of annual surveillance imaging in an adult and paediatric cohort of succinate dehydrogenase B mutation carriers . Clinical Endocrinology vol. 86 , ( 2 ) 286 - 296 .
Afghan WK, Iacovazzo D, Alevizaki M, Foulkes W, Lugli F, Druce M, Dutta P, Dang MN et al. ( 2016 ) . ESR2 mutations in RET mutation-negative familial medullary thyroid carcinoma . Endocrine Abstracts
Druce MR, Hickey A, Warrens AN, Westwood OMR ( 2016 ) . Medical Students Raising Concerns . Journal of Patient Safety vol. 17 , ( 5 ) e367 - e372 .
Srirangalingam U, Banerjee A, Patki P, Peters J, George E, Chew SL, Kumar VKA, Korbonits M et al. ( 2016 ) . Succinate Dehydrogenase B (SDHB)-Associated Bladder Paragangliomas . Clinical Genitourinary Cancer vol. 15 , ( 1 ) e131 - e136 .
Qureshi SA, Burch N, Druce M, Hattersley JG, Khan S, Gopalakrishnan K, Darby C, Wong JLH et al. ( 2016 ) . Screening for malnutrition in patients with gastro-entero-pancreatic neuroendocrine tumours: a cross-sectional study . BMJ Open vol. 6 , ( 5 ) e010765 - e010765 .
O'Toole S, Sze C, Tirador K, Akker S, Matson M, Perry L, Druce M, Dekkers T et al. ( 2015 ) . Adrenal vein catecholamine levels and ratios: reference intervals derived from patients with primary aldosteronism . Endocrine Abstracts
O'Toole S, Glynn N, Gouveia C, Windt RS, Stiles C, Sivapackianathan R, Akker S, Druce M et al. ( 2015 ) . Out-of-hours cover for diabetes and endocrinology: a single UK tertiary centre experience . Endocrine Abstracts
Sivapackianathan R, Suriyakumaran J, Akker S, Drake W, Waterhouse M, Druce M ( 2015 ) . Traditional cardiac risk factors in a cohort of hypopituitary patients: a preliminary look at the utility of QRISK2 score . Endocrine Abstracts
Marques P, Van Huellen H, Fitzpatrick A, Druce M ( 2015 ) . Late endocrine effects of cancer and cancer therapies in survivors of childhood malignancies . Minerva Endocrinologica vol. 41 , ( 1 ) 78 - 104 .
Roff S, Druce M, Livingston K, Roberts CM, Stephenson A ( 2015 ) . Mapping Norms of Academic Integrity as an Aid to Proactive Regulation . Journal of Medical Regulation vol. 101 , ( 3 ) 24 - 31 .
Srirangalingam U, Banerjee A, George E, Druce M, Waterhouse M, Chew SL, Peters J, Patki P et al. ( 2015 ) . Succinate dehydrogenase B associated bladder paragangliomas . Endocrine Abstracts
Soh LM, Druce M, Grossman AB, Differ A-M, Rajput L, Bitner-Glindzicz M, Korbonits M ( 2015 ) . Evaluation of genotype-phenotype relationships in patients referred for endocrine assessment in suspected Pendred syndrome . Eur J Endocrinol vol. 172 , ( 2 ) 217 - 226 .
Dénes J, Swords F, Rattenberry E, Stals K, Owens M, Cranston T, Xekouki P, Moran L et al. ( 2014 ) . Heterogeneous Genetic Background of the Association of Pheochromocytoma/Paraganglioma and Pituitary Adenoma: Results From a Large Patient Cohort . The Journal of Clinical Endocrinology & Metabolism vol. 100 , ( 3 ) e531 - e541 .
Druce M ( 2014 ) . Addressing quality in endocrine care . Clinical Endocrinology vol. 81 , ( 6 ) 818 - 819 .
Schoenmakers N, Moran C, Campi I, Agostini M, Bacon O, Rajanayagam O, Schwabe J, Bradbury S et al. ( 2014 ) . A novel albumin gene mutation (R222I) in familial dysalbuminemic hyperthyroxinemia . J Clin Endocrinol Metab vol. 99 , ( 7 ) E1381 - E1386 .
Sze WCC, Soh LM, Lau JH, Reznek R, Sahdev A, Matson M, Riddoch F, Carpenter R et al. ( 2014 ) . Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous sampling . Clin Endocrinol (Oxf) vol. 81 , ( 1 ) 25 - 30 .
Gunganah K, Grossman A, Druce M ( 2014 ) . Recurrent pancreatitis in a patient with familial hypocalciuric hypercalcaemia treated successfully with cinacalcet . Endocrinology Diabetes and Metabolism Case Reports vol. 2014 , ( 1 )
Srirangalingam U, Khan F, Gunganah K, Sahdev A, Waterhouse M, Druce MR, Drake WM, Akker SA ( 2014 ) . SDHB surveillance regime: a single UK institution experience . Endocrine Abstracts
Sen Gupta P, Grozinsky-Glasberg S, Drake WM, Akker SA, Perry L, Grossman AB, Druce MR ( 2014 ) . Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours? . Clin Endocrinol (Oxf) vol. 80 , ( 2 ) 246 - 252 .
Solomou S, Khan R, Propper D, Berney D, Druce M ( 2014 ) . A case of insulin and ACTH co-secretion by a neuroendocrine tumour . Endocrinol Diabetes Metab Case Rep vol. 2014 ,
Druce M ( 2014 ) . Addressing quality in endocrine care . Clinical Endocrinology
Yang L, Mann K, Winceslaus J, Khan R, Berney D, Akker S, Waterhouse M, Drake W et al. ( 2014 ) . Characteristics of 'foregut' carcinoid tumours occurring in multiple endocrine neoplasia type 1 (MEN1) . WIENER KLINISCHE WOCHENSCHRIFT . vol. 126 , S147 - S147 .
Banerjee A, Srirangalingam U, George E, Berney D, Patki P, Peters J, Druce M, Waterhouse M et al. ( 2014 ) . Clinical Manifestations of SDH Associated Bladder Paragangliomas . ENDOCRINE REVIEWS . vol. 35 ,
Bhattacharya S, Vyas S, Drake WM, Druce M ( 2014 ) . Localisation and surgical resection of pancreatic insulinomas . WIENER KLINISCHE WOCHENSCHRIFT . vol. 126 , S149 - S149 .
Soh LM, Druce M, Grossman AB, Differ A-M, Rajput L, Bitner-Glindzicz M, Korbonits M ( 2014 ) . Strong Genotype-Phenotype Correlation in Pendred Syndrome Allows Reduced Endocrine Follow-up in Suitable Patients . ENDOCRINE REVIEWS . vol. 35 ,
Nadarasa K, Bailey M, Chahal H, Raja O, Bhat R, Gayle C, Grossman AB, Druce MR ( 2014 ) . The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma . Endocrinol Diabetes Metab Case Rep vol. 2014 ,
Sze WCC, Grossman AB, Goddard I, Amendra D, Shieh SCC, Plowman PN, Drake WM, Akker SA et al. ( 2013 ) . Sequelae and survivorship in patients treated with (131)I-MIBG therapy . Br J Cancer vol. 109 , ( 3 ) 565 - 572 .
Hussain S, Gunganah K, Ashby M, Carpenter R, Waterhouse M, Druce M, Drake W, Akker S ( 2013 ) . Peri-operative [a]-blockade: efficacy of intravenous phenoxybenzamine vs oral phenoxybenzamine in patients with phaeochromocytoma and paraganglioma . Endocrine Abstracts1 - 1 .
Denes J, Swords F, Rattenberry E, Xekouki P, Kumar A, Wassif C, Fersht N, Baldeweg S et al. ( 2013 ) . Pituitary adenoma and phaeochromocytoma/paraganglioma - a novel syndrome with a heterogeneous genetic background . Endocrine Abstracts1 - 1 .
O'Toole S, Pittaway J, Raja O, Buckland M, Plowman N, Brennan C, Waterhouse M, Akker S et al. ( 2013 ) . Prevalence of anti-thyroglobulin antibodies, their prognostic significance and impact on patient care in a cohort of patients with differentiated thyroid cancer . Endocrine Abstracts1 - 1 .
Herincs M, Antwi SO, Chahal HS, Kumar SR, Ozfirat Z, Grossman AB, Druce MR, Akker SA et al. ( 2013 ) . Prevalence of familial isolated pituitary adenomas . Endocrine Abstracts1 - 1 .
Druce M, Chung T-T, Grozinsky-Glasberg S, Gross DJ, Grossman AB ( 2012 ) . Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma . Clin Endocrinol (Oxf) vol. 77 , ( 1 ) 154 - 155 .
Martins RG, Agrawal R, Berney DM, Reznek R, Matson M, Grossman AB, Druce MR ( 2012 ) . Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling . Endocr Pract vol. 18 , ( 6 ) e153 - e157 .
Druce MR, Walker D, Maher KT, Dodzo K, Perry L, Ball S, Peaston R, Chew SL et al. ( 2011 ) . The effect of exogenous glucocorticoids on plasma catecholamines and metanephrines in patients without phaeochromocytomas . Horm Metab Res vol. 43 , ( 4 ) 292 - 295 .
Den Gupta P, Grozinsky-Glasberg S, Shimon I, Drake W, Akker S, Chew S, Grossman A, Druce M ( 2011 ) . Evaluation of the Association between Serotonin and Bone Mineral Density in Patients with Neuroendocrine Tumors . NEUROENDOCRINOLOGY . vol. 94 , 23 - 23 .
Druce MR, Walker D, Maher KT, Dodzo K, Perry L, Ball S, Peaston R, Chew SL et al. ( 2011 ) . The Effect of Exogenous Glucocorticoids on Plasma Catecholamines and Metanephrines in Patients Without Phaeochromocytomas . Hormone and Metabolic Research
Druce MR, Muthuppalaniappan VM, O'Leary B, Chew SL, Drake WM, Monson JP, Akker SA, Besser M et al. ( 2010 ) . Diagnosis and localisation of insulinoma: The value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation (European Journal of Endocrinology 162, (971)) . European Journal of Endocrinology vol. 162 , ( 6 )
Druce MR, Muthuppalaniappan VM, O'Leary B, Chew SL, Drake WM, Monson JP, Akker SA, Besser M et al. ( 2010 ) . Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation (vol 162, 971, 2010) . EUR J ENDOCRINOL vol. 162 , ( 6 ) 1165 - 1165 .
Druce MR, Muthuppalaniappan VM, O'Leary B, Chew SL, Drake WM, Monson JP, Akker SA, Besser M et al. ( 2010 ) . Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation . Eur J Endocrinol vol. 162 , ( 5 ) 971 - 978 .
Druce MR, Akker SA, Chew SL, Drake WM, Grossman AB ( 2010 ) . Morbidity in patients on long-term steroid replacement therapy . Clin Endocrinol (Oxf) vol. 72 , ( 4 ) 564 - 566 .
Druce MR, Bharwani N, Akker SA, Drake WM, Rockall A, Grossman AB ( 2010 ) . Intra-abdominal fibrosis in a recent cohort of patients with neuroendocrine ('carcinoid') tumours of the small bowel . QJM vol. 103 , ( 3 ) 177 - 185 .
Liu YL, Ford HE, Druce MR, Minnion JS, Field BC, Shillito JC, Baxter J, Murphy KG et al. ( 2010 ) . Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents . International Journal of Obesity vol. 34 , 1715 - 1725 .
Druce MR, Lewington V, Grossman AB ( 2010 ) . Targeted radionuclide therapy for neuroendocrine tumours: principles and application . Neuroendocrinology vol. 91 , ( 1 ) 1 - 15 .
Coelho C, Druce MR, Grossman AB ( 2009 ) . Diagnosis of insulinoma in a patient with hypoglycemia without obvious hyperinsulinemia . NAT REV ENDOCRINOL vol. 5 , ( 11 ) 628 - 631 .
Druce MR, Kaltsas GA, Fraenkel M, Gross DJ, Grossman AB ( 2009 ) . Novel and evolving therapies in the treatment of malignant phaeochromocytoma: experience with the mTOR inhibitor everolimus (RAD001) . Horm Metab Res vol. 41 , ( 9 ) 697 - 702 .
Druce M, Rockall A, Grossman AB ( 2009 ) . Fibrosis and carcinoid syndrome: from causation to future therapy . Nat Rev Endocrinol vol. 5 , ( 5 ) 276 - 283 .
Druce MR, Bharwani N, Akker SA, Chew SL, Drake WM, Rockall A, Grossman AB ( 2009 ) . Intra-abdominal fibrosis in a modern cohort of patients with mid-gut carcinoid tumours - a cross-sectional survey from one centre . EUR J CLIN INVEST vol. 39 , 19 - 19 .
Druce MR, Minnion JS, Field BC, Patel SR, Shillito JC, Tilby M, Beale KE, Murphy KG et al. ( 2009 ) . Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogues . Endocrinology vol. 150 , ( 4 ) 1712 - 1722 .
Druce M, Goldstone AP, Tan TMM, Meeran K ( 2008 ) . The pursuit of beauty . LANCET vol. 371 , ( 9612 ) 596 - 596 .
Chaudhri OB, Parkinson JRC, Kuo YT, Druce MR, Herlihy AH, Bell JD, Dhillo WS, Stanley SA et al. ( 2006 ) . Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging . BIOCHEM BIOPH RES CO vol. 350 , ( 2 ) 298 - 306 .
Druce MR, Neary NM, Small CJ, Milton J, Monteiro M, Patterson M, Ghatei MA, Bloom SR ( 2006 ) . Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers . INT J OBESITY vol. 30 , ( 2 ) 293 - 296 .
Druce M, Bloom SR ( 2006 ) . The regulation of appetite . ARCH DIS CHILD vol. 91 , ( 2 ) 183 - 187 .
Neary NM, Druce MR, Small CJ, Bloom SR ( 2006 ) . Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect . GUT vol. 55 , ( 1 ) 135 - 135 .
Druce M, Ghatei M ( 2006 ) . Oxyntomodulin . Current Opinion in Endocrinology and Diabetes vol. 13 , ( 1 ) 49 - 55 .
Druce MR, Bloom SR ( 2006 ) . Oxyntomodulin : a novel potential treatment for obesity . Treat Endocrinol vol. 5 , ( 5 ) 265 - 272 .
Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K et al. ( 2005 ) . Peptide YY3-36 and glucagon-like peptide-1(7-36) inhibit food intake additively . ENDOCRINOLOGY vol. 146 , ( 12 ) 5120 - 5127 .
Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, Ghatei MA, Small C et al. ( 2005 ) . Ghrelin increases food intake in obese as well as lean subjects . INT J OBESITY vol. 29 , ( 9 ) 1130 - 1136 .
Druce MR, Wren AM, Park AJ, Milton JE, Patterson M, Frost G, Ghatei MA, Small C et al. ( 2005 ) . Ghrelin increases food intake in obese as well as lean subjects . Int J Obes (Lond) vol. 29 , ( 9 ) 1130 - 1136 .
Neary NM, Small CJ, Wren AM, Lee JL, Druce MR, Palmieri C, Frost GS, Ghatei MA et al. ( 2004 ) . Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial . J CLIN ENDOCR METAB vol. 89 , ( 6 ) 2832 - 2836 .
Druce MR, Small CJ, Bloom SR ( 2004 ) . Minireview: Gut peptides regulating satiety . ENDOCRINOLOGY vol. 145 , ( 6 ) 2660 - 2665 .
Druce M, Bloom SR ( 2003 ) . Central regulators of food intake . CURR OPIN CLIN NUTR vol. 6 , ( 4 ) 361 - 367 .
Druce M, Bloom SR ( 2003 ) . Central regulators of food intake . Curr Opin Clin Nutr Metab Care vol. 6 , ( 4 ) 361 - 367 .
Druce M, Morris VH, Stamp TCB ( 2002 ) . A case report of myositis ossificans progressiva complicated by femoral nerve compression treated with radiotherapy . RHEUMATOLOGY vol. 41 , ( 8 ) 947 - 948 .
Druce M, Morris VH, Stamp TCB ( 2001 ) . A case of neurapraxia secondary to myositis ossificans progressiva, treated with radiotherapy . BONE . vol. 28 , S122 - S122 .
Druce M, Cohen IJ, Naor N, Shohat M ( 1995 ) . Late diagnosis of Down syndrome due to incorrect cytogenetic diagnosis and extreme prematurity . Clin Genet vol. 48 , ( 4 ) 192 - 194 .